Author

Chang Liu

Johns Hopkins UniversityORCID 0000-0001-5144-1736Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Chang Liu21 papers · Columbia University Irving Medical Center

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aira SarkariD· 1 shared Huadong YiniD· 1 shared Jialin Xiang· 1 shared Jing ZhaoiD· 1 shared Kathleen L. GabrielsoniD· 1 shared Pooja HariharaniD· 1 shared Qing Chun ZhuiD· 1 shared Rajiv NairiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Aira SarkarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyPLoS GeneticsPeer-reviewedDec 18, 2025

Circular RNA profiling revealed an evolutionarily conserved circACACA promotes liver lipid metabolism, oxidative stress, and autophagy disorder in a ceRNA manner

Jing Zhao, Shunshun Han, Jialin Xiang…·Huadong Yin

This study identifies circACACA as an evolutionarily conserved circRNA that disrupts lipid metabolism and induces oxidative stress and autophagy disorder in NAFLD through a ceRNA mechanism.

4 citations

chicken / avianscRNA-seq

𝕏 PostBluesky

BioengineeringbioRxivPreprintAug 25, 2025

Actinium-225 dendrimer-radioconjugates combined with low-dose standard-of-care chemotherapy: site-independent treatment of triple negative breast cancer metastases

Pooja Hariharan, Rajiv Nair, Aira Sarkar…·Stavroula Sofou

This study evaluates dendrimer-radioconjugates with Actinium-225 and low-dose cisplatin for treating metastatic triple negative breast cancer across different anatomical sites in mice, showing improved survival without long-term toxicity.

DOI 10.1101/2025.08.25.670941

mouseexperimental assay

𝕏 PostBluesky